Atrogi’s solution has the potential to revolutionize the life of everyone who currently has or in the future will suffer from type 2 diabetes.

Atrogi’s solution focuses on fully functioning and healthy systems in the body, circumventing the dysfunctional insulin pathway in type 2 diabetic patients. The result is lowered blood glucose levels and a decreased risk of devastating secondary diseases.

Insulin independent

A chance to live your life with normal blood sugar levels.

Prolonged healthy life

Atrogi’s solution will decrease the risk of secondary diseases caused by type 2 diabetes.

We offer an exceptional solution

  • A potential first in class drug with a unique mechanism for the oral treatment of T2D
  • A drug that:
    • shows powerful effect on glucose homeostasis in animal models
    • shows several added advantageous effects
    • is covered by strong IP
  • Ongoing pre-clinical studies in preparation for First in Human studies (2021)
  • Large interest from big pharma

Research collaborations and funding


The development of the new compound is run by a Swedish research company and entails a completely new solution to the global challenge with type 2 diabetes. We are a dedicated team with more than 20 years of experience in this field of research.


We are a multi-disciplinary team committed to focused and efficient drug development.